K. Chapman, A. Coutinho, M. Gray, J. Gilmour, J. Savill et al., Local Amplification of Glucocorticoids by 11beta-Hydroxysteroid Dehydrogenase Type 1 and Its Role in the Inflammatory Response, Annals of the New York Academy of Sciences, vol.82, issue.1, pp.265-273, 2006.
DOI : 10.1146/annurev.immunol.19.1.163

M. Karin, New Twists in Gene Regulation by Glucocorticoid Receptor: Is DNA Binding Dispensable?, Cell, vol.93, issue.4, pp.487-490, 1998.
DOI : 10.1016/S0092-8674(00)81177-0

M. Ricketts, J. Verhaeg, I. Bujalska, A. Howie, W. Rainey et al., Immunohistochemical localization of type 1 11beta-hydroxysteroid dehydrogenase in human tissues, J Clin Endocrinol Metab, vol.83, pp.1325-1335, 1998.

G. Pelletier, V. Luu-the, S. Li, G. Bujold, and F. Labrie, Localization and glucocorticoid regulation of 11??-hydroxysteroid dehydrogenase type 1 mRNA in the male mouse forebrain, Neuroscience, vol.145, issue.1, pp.110-115, 2007.
DOI : 10.1016/j.neuroscience.2006.11.038

L. Freeman, M. Hewison, S. Hughes, K. Evans, D. Hardie et al., Expression of 11??-hydroxysteroid dehydrogenase type 1 permits regulation of glucocorticoid bioavailability by human dendritic cells, Blood, vol.106, issue.6, pp.2042-2049, 2005.
DOI : 10.1182/blood-2005-01-0186

R. Thieringer, L. Grand, C. Carbin, L. Cai, T. Wong et al., 11??-Hydroxysteroid Dehydrogenase Type 1 Is Induced in Human Monocytes upon Differentiation to Macrophages, The Journal of Immunology, vol.167, issue.1, pp.30-35, 2001.
DOI : 10.4049/jimmunol.167.1.30

G. Chinetti, J. Fruchart, and B. Staels, Peroxisome proliferator-activated receptors and inflammation: from basic science to clinical applications, International Journal of Obesity, vol.27, pp.41-45, 2003.
DOI : 10.1038/sj.ijo.0802499

A. Mantovani, A. Sica, S. Sozzani, P. Allavena, A. Vecchi et al., The chemokine system in diverse forms of macrophage activation and polarization, Trends in Immunology, vol.25, issue.12, pp.677-686, 2004.
DOI : 10.1016/j.it.2004.09.015

S. Kliewer, J. Lenhard, T. Willson, I. Patel, D. Morris et al., A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor ?? and promotes adipocyte differentiation, Cell, vol.83, issue.5, pp.813-819, 1995.
DOI : 10.1016/0092-8674(95)90194-9

G. Pascual, A. Fong, S. Ogawa, A. Gamliel, A. Li et al., A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-??, Nature, vol.28, issue.7059, pp.759-763, 2005.
DOI : 10.1038/35056591

J. Odegaard, R. -. Gonzalez, R. Goforth, M. Morel, C. Subramanian et al., Macrophage-specific PPAR?? controls alternative activation and improves insulin resistance, Nature, vol.292, issue.7148, pp.1116-1120, 2007.
DOI : 10.1038/nature05894
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2587297

M. Bouhlel, B. Derudas, E. Rigamonti, R. Dievart, J. Brozek et al., PPAR?? Activation Primes Human Monocytes into Alternative M2 Macrophages with Anti-inflammatory Properties, Cell Metabolism, vol.6, issue.2, pp.137-143, 2007.
DOI : 10.1016/j.cmet.2007.06.010

G. Chinetti, S. Griglio, M. Antonucci, P. Torra, I. Delerive et al., Activation of Proliferator-activated Receptors ?? and ?? Induces Apoptosis of Human Monocyte-derived Macrophages, Journal of Biological Chemistry, vol.273, issue.40, pp.25573-25580, 1998.
DOI : 10.1074/jbc.273.40.25573

N. Wang, D. Lan, W. Chen, F. Matsuura, and A. Tall, ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins, Proceedings of the National Academy of Sciences, vol.101, issue.26, pp.9774-9779, 2004.
DOI : 10.1073/pnas.0403506101
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC470750

D. Odom, R. Dowell, E. Jacobsen, L. Nekludova, P. Rolfe et al., Core transcriptional regulatory circuitry in human hepatocytes, Molecular Systems Biology, vol.102, p.17, 2006.
DOI : 10.1038/msb4100059

R. Nielsen, T. Pedersen, D. Hagenbeek, P. Moulos, R. Siersbaek et al., Genome-wide profiling of PPAR??:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis, Genes & Development, vol.22, issue.21, pp.2953-2967, 2008.
DOI : 10.1101/gad.501108

E. Rigamonti, C. Fontaine, B. Lefebvre, C. Duhem, P. Lefebvre et al., Induction of CXCR2 Receptor by Peroxisome Proliferator-Activated Receptor gamma in { }

S. Low, K. Chapman, C. Edwards, and J. Seckl, 'Liver-type' 11??-hydroxysteroid dehydrogenase cDNA encodes reductase but not dehydrogenase activity in intact mammalian COS-7 cells, Journal of Molecular Endocrinology, vol.13, issue.2, pp.167-174, 1994.
DOI : 10.1677/jme.0.0130167

G. Lavery, E. Walker, N. Draper, P. Jeyasuria, M. J. Shackleton et al., Hexose-6-phosphate Dehydrogenase Knock-out Mice Lack 11beta-Hydroxysteroid Dehydrogenase Type 1-mediated Glucocorticoid Generation, Journal of Biological Chemistry, vol.281, issue.10, pp.6546-6551, 2006.
DOI : 10.1074/jbc.M512635200

S. Koliwad, T. Kuo, L. Shipp, N. Gray, F. Backhed et al., Angiopoietin-like 4 (ANGPTL4, Fasting-induced Adipose Factor) Is a Direct Glucocorticoid Receptor Target and Participates in Glucocorticoid-regulated Triglyceride Metabolism, Journal of Biological Chemistry, vol.284, issue.38, pp.25593-25601, 2009.
DOI : 10.1074/jbc.M109.025452

S. Connaughton, F. Chowdhury, R. Attia, S. Song, Y. Zhang et al., Regulation of pyruvate dehydrogenase kinase isoform 4 (PDK4) gene expression by glucocorticoids and insulin, Molecular and Cellular Endocrinology, vol.315, issue.1-2, pp.159-167, 2010.
DOI : 10.1016/j.mce.2009.08.011

L. Leesnitzer, D. Parks, R. Bledsoe, J. Cobb, J. Collins et al., Functional Consequences of Cysteine Modification in the Ligand Binding Sites of Peroxisome Proliferator Activated Receptors by GW9662, Biochemistry, vol.41, issue.21, pp.6640-6650, 2002.
DOI : 10.1021/bi0159581

J. Ernst, P. Kheradpour, T. Mikkelsen, N. Shoresh, L. Ward et al., Mapping and analysis of chromatin state dynamics in nine human cell types, Nature, vol.125, issue.7345, pp.43-49, 2011.
DOI : 10.1038/nature09906

C. Staab, J. Stegk, S. Haenisch, E. Neiss, K. Kobsch et al., Analysis of alternative promoter usage in expression of HSD11B1 including the development of a transcript-specific quantitative real-time PCR method, Chemico-Biological Interactions, vol.191, issue.1-3, pp.104-112, 2011.
DOI : 10.1016/j.cbi.2010.12.027

C. Beck, P. Estes, B. Bona, C. Muro-cacho, S. Nordeen et al., The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors, Endocrinology, vol.133, pp.728-740, 1993.

T. Engel, S. Lorkowski, A. Lueken, S. Rust, B. Schluter et al., The Human ABCG4 Gene Is Regulated by Oxysterols and Retinoids in Monocyte-Derived Macrophages, Biochemical and Biophysical Research Communications, vol.288, issue.2
DOI : 10.1006/bbrc.2001.5756

A. Cazes, A. Galaup, C. Chomel, M. Bignon, N. Brechot et al., Extracellular Matrix-Bound Angiopoietin-Like 4 Inhibits Endothelial Cell Adhesion, Migration, and Sprouting and Alters Actin Cytoskeleton, Circulation Research, vol.99, issue.11, pp.1207-1215, 2006.
DOI : 10.1161/01.RES.0000250758.63358.91
URL : https://hal.archives-ouvertes.fr/inserm-00177171

J. Gilmour, A. Coutinho, J. Cailhier, T. Man, M. Clay et al., Local Amplification of Glucocorticoids by 11??-Hydroxysteroid Dehydrogenase Type 1 Promotes Macrophage Phagocytosis of Apoptotic Leukocytes, The Journal of Immunology, vol.176, issue.12, pp.7605-7611, 2006.
DOI : 10.4049/jimmunol.176.12.7605

T. Zhang and R. Daynes, Macrophages from 11??-Hydroxysteroid Dehydrogenase Type 1-Deficient Mice Exhibit an Increased Sensitivity to Lipopolysaccharide Stimulation Due to TGF-??-Mediated Up-Regulation of SHIP1 Expression, The Journal of Immunology, vol.179, issue.9, pp.6325-6335, 2007.
DOI : 10.4049/jimmunol.179.9.6325